A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis

The p53 protein has recently been reported to be capable of mediating apoptosis through a pathway that is not dependent on its transactivation function. We report here that the PIASy member of the protein inhibitor of activated STAT family inhibited p53's transactivation function without compromising its ability to induce apoptosis of the H1299 nonsmall cell lung carcinoma cell line. The p53 protein bound to PIASy in yeast two-hybrid assays and coprecipitated in complexes with p53 in immunoprecipitates from mammalian cells. PIASy inhibited the DNA-binding activity of p53 in nuclear extracts and blocked the ability of p53 to induce expression of two of its target genes, Bax and p21Waf1/Cip1, in H1299 cells. The block in p53-mediated induction of Bax and p21 was determined to be at the level of transactivation, since PIASy inhibited p53's ability to transactivate a p21/luciferase reporter construct. PIASy did not effect the incidence of apoptosis in H1299 cells upregulated for p53. PIASy appears to regulate p53-mediated functions and may direct p53 into a transactivation-independent mode of apoptosis.

[1]  S. Maxwell,et al.  Biological and molecular characterization of an ECV-304-derived cell line resistant to p53-mediated apoptosis , 2000, Apoptosis.

[2]  A. Levine,et al.  Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. , 1991, Genes & development.

[3]  A. Ward.  Single-step purification of shuttle vectors from yeast for high frequency back-transformation into E. coli. , 1990, Nucleic acids research.

[4]  A G Yakovlev,et al.  Role of Poly(ADP-ribose) Polymerase (PARP) Cleavage in Apoptosis , 1999, The Journal of Biological Chemistry.

[5]  B. Vogelstein,et al.  Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  N. Tsuchida,et al.  Activation of Caspases in p53‐induced Transactivation‐independent Apoptosis , 1999, Japanese journal of cancer research : Gann.

[7]  K. Roemer,et al.  A function in apoptosis other than transactivation inherent in the NH2‐terminal domain of p53 , 1997, International journal of cancer.

[8]  R Montesano,et al.  Database of p53 gene somatic mutations in human tumors and cell lines. , 1994, Nucleic acids research.

[9]  A. Boulares,et al.  Transient Poly(ADP-ribosyl)ation of Nuclear Proteins and Role of Poly(ADP-ribose) Polymerase in the Early Stages of Apoptosis* , 1998, The Journal of Biological Chemistry.

[10]  P. Meltzer,et al.  Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.

[11]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[12]  G. Salvesen,et al.  Cleavage of Automodified Poly(ADP-ribose) Polymerase during Apoptosis , 1999, The Journal of Biological Chemistry.

[13]  R. Jove,et al.  Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. , 1998, Journal of biomedical science.

[14]  E. Wagner,et al.  Down‐regulation of wild‐type p53 activity interferes with apoptosis of IL‐3‐dependent hematopoietic cells following IL‐3 withdrawal. , 1994, The EMBO journal.

[15]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[16]  L. Breeden,et al.  Regulation of the yeast HO gene. , 1985, Cold Spring Harbor symposia on quantitative biology.

[17]  W. El-Deiry,et al.  Regulation of p53 downstream genes. , 1998, Seminars in cancer biology.

[18]  T Takahashi,et al.  Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. , 1992, Cancer research.

[19]  A. Kimchi,et al.  p53-mediated cell death: relationship to cell cycle control , 1993, Molecular and cellular biology.

[20]  C J Kemp,et al.  The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. , 1994, Cancer research.

[21]  S. Maxwell,et al.  Expression of Bax, Bcl-2, Waf-1, and PCNA gene products in an immortalized human endothelial cell line undergoing p53-mediated apoptosis , 2004, Apoptosis.

[22]  B. Vogelstein,et al.  p53 functions as a cell cycle control protein in osteosarcomas , 1990, Molecular and cellular biology.

[23]  C. Prives,et al.  The p53 pathway , 1999, The Journal of pathology.

[24]  A. Levine,et al.  Gas1-induced growth suppression requires a transactivation-independent p53 function , 1995, Molecular and cellular biology.

[25]  C. Purdie,et al.  Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.

[26]  Johnny J. He,et al.  Thrombopoietin-induced conformational change in p53 lies downstream of the p44/p42 mitogen activated protein kinase cascade in the human growth factor-dependent cell line M07e , 1999, Oncogene.

[27]  Thea D. Tlsty,et al.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 , 1992, Cell.

[28]  A. Levine,et al.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.

[29]  G. Wahl,et al.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles , 1992, Cell.

[30]  G. Garcı́a-Cardeña,et al.  Biological action of leptin as an angiogenic factor. , 1998, Science.

[31]  P. Sehgal,et al.  Regulation of IL-6 signaling by p53: STAT3- and STAT5-masking in p53-Val135-containing human hepatoma Hep3B cell lines. , 1998, Journal of immunology.

[32]  E. Appella,et al.  Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  G. Salvesen,et al.  Caspases: Intracellular Signaling by Proteolysis , 1997, Cell.

[34]  Bert Vogelstein,et al.  Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 , 1993, Nature.

[35]  K. Elkon.  Caspases , 1999, The Journal of Experimental Medicine.

[36]  K. Murata,et al.  Transformation of intact yeast cells treated with alkali cations. , 1984, Journal of bacteriology.

[37]  D. Chang,et al.  Inhibition of Stat1-mediated gene activation by PIAS1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Yusuke Nakamura,et al.  A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage , 2000, Nature.

[39]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[40]  B. Groner,et al.  p53 suppresses cytokine induced, Stat5 mediated activation of transcription , 1998, Molecular and Cellular Endocrinology.

[41]  P. Howley,et al.  Mutations in serines 15 and 20 of human p53 impair its apoptotic activity , 1999, Oncogene.

[42]  K. Dameron,et al.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.

[43]  J. Becker,et al.  a v b 3 during Angiogenesis , 1996 .

[44]  Timothy Hoey.  A New Player in Cell Death , 1997, Science.

[45]  V. Rotter,et al.  Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage. , 1993, Oncogene.

[46]  K. Roemer,et al.  Function, oligomerization, and conformation of tumor‐associated p53 proteins with mutated C‐terminus , 2000, Journal of cellular biochemistry.

[47]  A. Giaccia,et al.  The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.

[48]  J. Ihle.  STATs: Signal Transducers and Activators of Transcription , 1996, Cell.

[49]  E. White,et al.  Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.